Shuling Han
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Colorectal Cancer Treatments and Studies
-
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Psoriasis: Treatment and Pathogenesis
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
-
- RNA modifications and cancer 2
- Ubiquitin and proteasome pathways 1
- Co-authors
- Yanqiao Zhang (13 shared papers)Lin Fang (8 shared papers)Chunhui Zhang (4 shared papers)Chao Liu (5 shared papers)Bojun Wang (7 shared papers)Haoxiu Sun (2 shared papers)Xin Guan (4 shared papers)Fei Zhan (2 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Cancer Letters (2 papers)Cancer Research and Treatment (1 paper)The International Journal of Biochemistry & Cell Biology (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Shuling Han
22 papers receiving 366 citations
Peers
Comparison fields: 5 of 57
- Oncology 161
- Immunology 94
- Cancer Research 33
- Pathology and Forensic Medicine 26
- Molecular Biology 78
Countries citing papers authored by Shuling Han
This map shows the geographic impact of Shuling Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuling Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuling Han more than expected).
Fields of papers citing papers by Shuling Han
This network shows the impact of papers produced by Shuling Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuling Han. The network helps show where Shuling Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuling Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 185 | |
| 2 | 2020 | 60 | |
| 3 | 2022 | 34 | |
| 4 | 2024 | 16 | |
| 5 | 2015 | 12 | |
| 6 | 2017 | 10 | |
| 7 | 2023 | 8 | |
| 8 | [Epidemiological investigation of back pain and spondyloarthritis in Shougang resident communities]. | 2010 | 8 |
| 9 | 2024 | 5 | |
| 10 | 2022 | 4 | |
| 11 | 2025 | 4 | |
| 12 | Effect of anti-tumor necrosis factor-alpha monoclonal antibody in alleviating renal ischemia-reperfusion injury. | 2003 | 4 |
| 13 | 2025 | 4 | |
| 14 | 2025 | 3 | |
| 15 | 2024 | 2 | |
| 16 | [Detection of CD95 and CD95L mRNA expression after liver transplantation using SYBR real-time PCR during acute rejection]. | 2006 | 2 |
| 17 | [Preparation and functional identification of testicular Sertoli cells]. | 2006 | 2 |
| 18 | 2016 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About Shuling Han
Shuling Han is a scholar working on Oncology, Molecular Biology, Immunology, Surgery and Pathology and Forensic Medicine, having authored 26 papers that have together received 368 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (2 papers), Immune cells in cancer (2 papers), Cancer Mechanisms and Therapy (2 papers), RNA modifications and cancer (2 papers), Ubiquitin and proteasome pathways (1 paper), Ferroptosis and cancer prognosis (1 paper) and Human Pose and Action Recognition (1 paper). The work is most often cited by research in Oncology (161 citations), Immunology (94 citations), Cancer Research (33 citations), Pathology and Forensic Medicine (26 citations) and Molecular Biology (78 citations). Shuling Han has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yanqiao Zhang, Lin Fang, Chunhui Zhang, Chao Liu, Bojun Wang, Haoxiu Sun, Xin Guan, Fei Zhan, Yuanfei Yao and Ruiqi Liu. Their work appears in journals such as Frontiers in Immunology, Cancer Letters, Cancer Research and Treatment, The International Journal of Biochemistry & Cell Biology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.